Banner Image

 

Twitter icon LinkedIn icon
Bray Chevron

MPIP in the News


 

MPIP Launches “What Transparency Means to Me”

May 8, 2017—Do you believe that reporting of industry-sponsored research in peer-reviewed journals should be transparent, balanced, and timely? Do you believe that ensuring transparency in medical communications represents an ethical imperative? Let your voice be heard, and tell us what transparency means to you!


MPIP Launches Transparency Matters

November 16, 2016—A new initiative of MPIP designed to raise awareness of the importance of transparency in reporting the results of industry-sponsored research and its impact on credibility. The goal is to broaden the conversation around transparency in medical publications, promote best practices, and engage interested parties in this important mission.


News relating to Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective. Lineberry N, Berlin JA, Mansi B, et al. BMJ. 2016;355:i5078

October 11, 2016—EQUATOR highlights MPIP reporting guidelines, noting that the five consensus recommendations supplement the guidance contained in the CONSORT Harms Extension.

View Article

October 10, 2016—Knowledgespeak highlights MPIP recommendations to improve adverse event reporting.

View Article

October 6, 2016Clinical Informatics News summarizes MPIP recommendations to improve adverse event reporting.

View Article


New Look for MPIP Website

October 3, 2016—We’ve updated our website with a new look and feel to coincide with the publication of Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective in The BMJ. The website update will make finding information about MPIP and our initiatives much easier, including content devoted to The BMJ article.


New MPIP Guidance on AE Reporting Now Available

October 3, 2016Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective provides guidance on clinically relevant and more informative adverse event reporting to improve patient care and increase the credibility of industry-sponsored publications published in The BMJ.

Learn More


MPIP Launches a Twitter Feed

October 3, 2016—Follow and visit us on Twitter .


Visit the New MPIP LinkedIn Page

September 6, 2016—MPIP is now on LinkedIn .


MPIP at ISMPP

April 11, 2016—MPIP authors presented their abstract, Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: A Survey of Journal Editors (CMRO. 2016;32(S1):S13) at the 2016 ISMPP meeting. As part of the poster tour at the meeting, our poster received many reviews and questions from those in attendance.

View the Abstract on page S13


Five‑Step Authorship Framework in the News

October 24, 2014—Medical Publishing Insights & Practices (MPIP) Publishes Five‑Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Trial Publications.

Learn More

 

Media Inquiries


If members of the media have inquiries for MPIP, please contact us.

 

Privacy Policy | Contact Us
Copyright © 2011-2016 MPIP. All Rights Reserved.